According to a recently published report, the global Companion Diagnostics Market has been expected to grow with an impressive double digit CAGR of 23.2% during 2016-2022. The global companion diagnostics market is segmented on the basis of application, technology, end user, and geography. The report on global companion diagnostics market forecast 2016-2022 (by application, technology, end user ,and geography) provides a detailed overview and predictive analysis of the market.
Full report is available on global companion diagnostics market forecast2016-2022 (by application, technology, end user, and geography)report at http://www.briskinsights.com/report/companion-diagnostics-market
According to the FDA, the companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The test helps a health care professional determine whether a particular therapeutic product’s benefits to patients will outweigh any potential serious side effects or risks. Due to the technological advancements, the market of companion diagnostic is growing rapidly, which is the major driver steering the growth of the market. The growing prevalence of diseases like HIV and cancer are propelling the companion diagnostic market, as they help in deciding the specific dosage of drugs for the patients. About the drugs toxicities, awareness among the patients and physicians is helping the market to grow. But, the costs involved in the research and development of the drugs is very high, which is becoming a major restraint for the companion diagnostics market.Lack of awareness among the patients and government policies and regulation are the major challengesfacing the market.
For Same Category Reports Visit Here: http://www.briskinsights.com/category/biotechnology-industry
Scope of the Report
- Global Companion Diagnostics Market by Application 2012-2022 ($ Million)
1.1. Colorectal Cancer
1.2. Breast Cancer
1.3. Lung Cancer
1.6. Gastric Cancer
- Global Companion Diagnostics Market by Technology 2012-2022 ($ Million)
2.1. Polymerase Chain Reaction (PCR)
2.2. In Situ Hybridization (ISH)
2.3. Immunohistochemistry (IHC)
2.4. Other Technologies (NGS,Multiplex Assay, Cellular Immune Testing, Mab)
- Global Companion Diagnostics Market by End User 2012-2022 ($ Million)
3.1. Pharmaceutical Companies
3.2. Reference Lab
3.3. Others (CRO, Physicians, Hospitals & Academic Medical Centers)
- Global Companion Diagnostics Market Regional Outlook 2012-2022($Million)
4.1. North America
4.3. Asia Pacific
4.4. Middle East & Africa
4.5. Latin America
- Company Profiles
5.1. Abbott Laboratories, Inc
5.3. Dako (Agilent Technologies)
5.4. Leica Microsystems
5.5. Life Technologies.
5.6. Myriad Genetics, Inc.
5.8. Resonance Health Ltd.
5.10. Ventana Medical Systems
5.11. Agilent Technologies, Inc.
5.12. BioGenex Laboratories
5.13. Danaher Corporation
5.14. Ge Healthcare
5.15. Thermo Fisher Scientific, Inc.
About Us :
Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies.
Working in a highly dynamic and multi-dimensional business makes decision making complex. Effective business decisions are a result of the synthesis of market information. Our Research and data analysis is an efficient and cost-effective way of providing robust market analysis and can yield highly valuable intelligence relating to consumers, competitors and markets.
Contact Us :
109 Vernon House
Phone : +448081890034 (UK)
Email : firstname.lastname@example.org
Website : http://www.briskinsights.com/
Release ID: 3257